Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01128_DB01222_nanopub.RAimfSGyepUQJh25qppMsutEU7wdrWhy6pj9ANNV1R4mo#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01128_DB01222 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01128_DB01222 label "DDI between Bicalutamide and Budesonide - CYP3A4 Inhibitors like bicalutamide may increase the serum concentration of budesonide. The clinical significance of this interaction is greater for oral budesonide than for orally inhaled budesonide. Consider reducing the oral budesonide dose when used together with a CYP3A4 inhibitor. [drugbank_resource:DB01128_DB01222]" assertion.
- drugbank_resource:DB01128_DB01222 identifier "drugbank_resource:DB01128_DB01222" assertion.
- drugbank_resource:DB01128_DB01222 title "DDI between Bicalutamide and Budesonide - CYP3A4 Inhibitors like bicalutamide may increase the serum concentration of budesonide. The clinical significance of this interaction is greater for oral budesonide than for orally inhaled budesonide. Consider reducing the oral budesonide dose when used together with a CYP3A4 inhibitor." assertion.
- drugbank:DB01222 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01128_DB01222 assertion.
- drugbank:DB01128 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01128_DB01222 assertion.